ADME DRIVE

LIVE

Serial Number

98212709

Owner

Superluminal Medicines, Inc.

Attorney

Gregory B. Coy

First Use Date

Feb 26, 2025

Filing Date

Oct 6, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ADME DRIVE Trademark

Serial Number: 98212709 • Registration: 8188369

ADME DRIVE is a trademark filed by Superluminal Medicines, Inc. on October 6, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Superluminal Medicines, Inc. (5 trademarks)

200 Berkeley Street, 18th Floor
Boston, MA 02116

Entity Type: 03

Legal Representation

Attorney of Record

Gregory B. Coy

547 trademarks filed View all →

Correspondence Address

Gregory B. Coy TAFT STETTINIUS & HOLLISTER LLP

One Indiana Square, Suite 3500

Indianapolis, IN 46204

United States

Trademark Details

Filing Date

October 6, 2023

Registration Date

March 24, 2026

First Use Anywhere

February 26, 2025

First Use in Commerce

August 14, 2025

Published for Opposition

July 9, 2024

Goods & Services

Development of pharmaceutical preparations and medicines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 24, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Mar 24, 2026 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 4, 2026 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 4, 2026 CNPR

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 2, 2026 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 2, 2026 CRFA

ASSIGNED TO LIE

Feb 24, 2026 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 19, 2026 TROA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 20, 2026 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 20, 2026 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 20, 2026 REAP

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 20, 2026 GNRN

NON-FINAL ACTION E-MAILED

Jan 20, 2026 GNRT

SU - NON-FINAL ACTION - WRITTEN

Jan 20, 2026 CNRT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 17, 2026 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Jan 17, 2026 SUPC

SOU EXTENSION 2 GRANTED

Jan 17, 2026 EX2G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 16, 2026 AITU

USE AMENDMENT FILED

Aug 29, 2025 IUAF

SOU EXTENSION 2 FILED

Aug 29, 2025 EXT2

SOU TEAS EXTENSION RECEIVED

Aug 29, 2025 EEXT

TEAS STATEMENT OF USE RECEIVED

Aug 29, 2025 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 4, 2025 EXRA

SOU EXTENSION 1 GRANTED

Mar 3, 2025 EX1G

SOU EXTENSION 1 FILED

Mar 3, 2025 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 3, 2025 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 3, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 9, 2024 NPUB

PUBLISHED FOR OPPOSITION

Jul 9, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 19, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 4, 2024 CNSA

ASSIGNED TO EXAMINER

May 28, 2024 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 14, 2023 NWOS

NEW APPLICATION ENTERED

Oct 10, 2023 NWAP

Related Trademarks

More from this Owner

SUPERLUMINAL MEDICINES

HYPERLOOP

SUPERLUMINAL MEDICINES

HYPERLOOP

TARGET GPS

More in Same Class

THUNDEX